HRP20020181B1 - Farmaceutski pripravci koji sadrže derivat benzamida kao aktivan sastojak - Google Patents
Farmaceutski pripravci koji sadrže derivat benzamida kao aktivan sastojakInfo
- Publication number
- HRP20020181B1 HRP20020181B1 HRP20020181AA HRP20020181A HRP20020181B1 HR P20020181 B1 HRP20020181 B1 HR P20020181B1 HR P20020181A A HRP20020181A A HR P20020181AA HR P20020181 A HRP20020181 A HR P20020181A HR P20020181 B1 HRP20020181 B1 HR P20020181B1
- Authority
- HR
- Croatia
- Prior art keywords
- benzamide derivative
- active ingredient
- pharmaceutical agent
- formulations
- mixing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Abstract
Stabilne farmaceutske formulacije mogu se dobiti miješanjem farmaceutski korisnog derivata benzamida ili njegove farmaceutski prihvatljive soli s aditivima koji ne daju lako produkte raspada, miješanjem soli organske kiseline, aminskog spoja i anorganske bazične supstancije, čime se dobivaju čvrste formulacije metodom suhog granuliranja, a zatim postavljanjem vrijednosti pH tekućih formulacija na vrijednost 4 do 12. Mogu se dobiti farmaceutske formulacije koje daju malo produkata raspada i koje su dovoljno stabilne da se koriste kao lijek.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP22955199A JP2001064177A (ja) | 1999-08-16 | 1999-08-16 | ベンズアミド誘導体を有効成分とする製剤 |
PCT/EP2000/008011 WO2001012193A1 (en) | 1999-08-16 | 2000-08-16 | Pharmaceutical agent comprising a benzamide derivative as active ingredient |
Publications (2)
Publication Number | Publication Date |
---|---|
HRP20020181A2 HRP20020181A2 (en) | 2005-10-31 |
HRP20020181B1 true HRP20020181B1 (hr) | 2016-01-29 |
Family
ID=16893948
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HRP20020181AA HRP20020181B1 (hr) | 1999-08-16 | 2002-02-27 | Farmaceutski pripravci koji sadrže derivat benzamida kao aktivan sastojak |
Country Status (29)
Country | Link |
---|---|
EP (1) | EP1207881B1 (hr) |
JP (2) | JP2001064177A (hr) |
KR (1) | KR100683876B1 (hr) |
CN (1) | CN1205931C (hr) |
AR (1) | AR031074A1 (hr) |
AU (1) | AU780151B2 (hr) |
BG (1) | BG65662B1 (hr) |
BR (1) | BR0013283A (hr) |
CA (1) | CA2380757C (hr) |
CY (1) | CY1116273T1 (hr) |
CZ (1) | CZ302924B6 (hr) |
DK (1) | DK1207881T3 (hr) |
EE (1) | EE05331B1 (hr) |
ES (1) | ES2536705T3 (hr) |
HK (1) | HK1046501B (hr) |
HR (1) | HRP20020181B1 (hr) |
HU (1) | HU230386B1 (hr) |
IL (1) | IL148169A0 (hr) |
MX (1) | MXPA02001575A (hr) |
NO (1) | NO328957B1 (hr) |
NZ (1) | NZ517356A (hr) |
PL (1) | PL201388B1 (hr) |
PT (1) | PT1207881E (hr) |
RU (1) | RU2257206C2 (hr) |
SK (1) | SK287547B6 (hr) |
TW (1) | TWI245630B (hr) |
UA (1) | UA73316C2 (hr) |
WO (1) | WO2001012193A1 (hr) |
ZA (1) | ZA200201466B (hr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001081031A (ja) * | 1999-08-30 | 2001-03-27 | Schering Ag | 溶解性および経口吸収性を改善したベンズアミド誘導体含有製剤 |
AU2001288102A1 (en) * | 2000-09-22 | 2002-04-02 | Takeda Chemical Industries Ltd. | Solid preparations |
IL163875A0 (en) | 2002-03-07 | 2005-12-18 | Univ Delaware | Methods, compositions, and kits for enhancing oli gonucleotide mediated nucleic acid sequence alteration using compositions comprising a histone de |
GB0316206D0 (en) | 2003-07-10 | 2003-08-13 | Glaxo Group Ltd | Pharmaceutical formulation |
KR20090125209A (ko) | 2007-03-28 | 2009-12-03 | 산텐 세이야꾸 가부시키가이샤 | 히스톤 탈아세틸화 효소 저해 작용을 갖는 화합물을 유효 성분으로서 함유하는 안압 하강제 |
KR101405615B1 (ko) * | 2007-08-27 | 2014-06-12 | (주)아모레퍼시픽 | 조성물 내 pH 조절을 통해 안정화된 벤즈아미드 화합물을함유하는 피부 외용제 조성물, 및 그 벤즈아미드 화합물안정화 방법 |
GB2462893B (en) * | 2008-08-29 | 2010-10-13 | Bayer Schering Pharma Ag | N-(2-aminophenyl)-4-[N-(pyridine-3-yl)-methoxycarbonyl-aminomethyl]-benzamide (MS-275) polymorph B |
PE20110677A1 (es) * | 2008-08-29 | 2011-09-16 | Bayer Ip Gmbh | Polimorfo b de la n-(2-aminofenil)-4-[n-(piridin-3-il) metoxicarbonilamino-metil]benzamida (ms-275) |
KR102142257B1 (ko) * | 2013-04-04 | 2020-08-07 | 다이이찌 산쿄 가부시키가이샤 | 아미노카르복실산의 염의 고형 조성물 |
WO2016148264A1 (ja) | 2015-03-19 | 2016-09-22 | 第一三共株式会社 | 着色剤を含有する固形製剤 |
JP6630343B2 (ja) | 2015-03-19 | 2020-01-15 | 第一三共株式会社 | 抗酸化剤を含有する固形製剤 |
WO2020153520A1 (ko) * | 2019-01-25 | 2020-07-30 | (주)아모레퍼시픽 | 벤조산아마이드 화합물 및 용해보조제를 포함하는 조성물 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0847992A1 (en) * | 1996-09-30 | 1998-06-17 | Mitsui Chemicals, Inc. | Benzamide derivatives, useful as cell differentiation inducers |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3354090B2 (ja) * | 1996-09-30 | 2002-12-09 | シエーリング アクチエンゲゼルシャフト | 分化誘導剤 |
-
1999
- 1999-08-16 JP JP22955199A patent/JP2001064177A/ja active Pending
-
2000
- 2000-08-07 TW TW089115860A patent/TWI245630B/zh not_active IP Right Cessation
- 2000-08-15 AR ARP000104212A patent/AR031074A1/es active IP Right Grant
- 2000-08-16 AU AU64427/00A patent/AU780151B2/en not_active Expired
- 2000-08-16 MX MXPA02001575A patent/MXPA02001575A/es active IP Right Grant
- 2000-08-16 SK SK209-2002A patent/SK287547B6/sk not_active IP Right Cessation
- 2000-08-16 KR KR1020027002002A patent/KR100683876B1/ko active IP Right Grant
- 2000-08-16 DK DK00951523.0T patent/DK1207881T3/da active
- 2000-08-16 EP EP00951523.0A patent/EP1207881B1/en not_active Expired - Lifetime
- 2000-08-16 IL IL14816900A patent/IL148169A0/xx active IP Right Grant
- 2000-08-16 HU HU0203226A patent/HU230386B1/hu unknown
- 2000-08-16 EE EEP200200073A patent/EE05331B1/xx unknown
- 2000-08-16 BR BR0013283-7A patent/BR0013283A/pt not_active Application Discontinuation
- 2000-08-16 CN CNB008117187A patent/CN1205931C/zh not_active Expired - Lifetime
- 2000-08-16 PT PT951523T patent/PT1207881E/pt unknown
- 2000-08-16 WO PCT/EP2000/008011 patent/WO2001012193A1/en active IP Right Grant
- 2000-08-16 CA CA002380757A patent/CA2380757C/en not_active Expired - Lifetime
- 2000-08-16 CZ CZ20020540A patent/CZ302924B6/cs not_active IP Right Cessation
- 2000-08-16 JP JP2001516539A patent/JP4854158B2/ja not_active Expired - Lifetime
- 2000-08-16 ES ES00951523.0T patent/ES2536705T3/es not_active Expired - Lifetime
- 2000-08-16 UA UA2002032040A patent/UA73316C2/uk unknown
- 2000-08-16 NZ NZ517356A patent/NZ517356A/en not_active IP Right Cessation
- 2000-08-16 PL PL353449A patent/PL201388B1/pl unknown
- 2000-08-16 RU RU2002106815/15A patent/RU2257206C2/ru active
-
2002
- 2002-02-15 NO NO20020774A patent/NO328957B1/no not_active IP Right Cessation
- 2002-02-21 ZA ZA200201466A patent/ZA200201466B/en unknown
- 2002-02-27 HR HRP20020181AA patent/HRP20020181B1/hr not_active IP Right Cessation
- 2002-03-14 BG BG106516A patent/BG65662B1/bg unknown
- 2002-10-22 HK HK02107641.6A patent/HK1046501B/zh not_active IP Right Cessation
-
2015
- 2015-05-13 CY CY20151100423T patent/CY1116273T1/el unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0847992A1 (en) * | 1996-09-30 | 1998-06-17 | Mitsui Chemicals, Inc. | Benzamide derivatives, useful as cell differentiation inducers |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1116273T1 (el) | Φαρμακευτικος παραγοντας που περιλαμβανει ενα παραγωγο βενζαμιδιου ως ενεργο συστατικο | |
ID26221A (id) | Komposisi-komposisi farmasi yang dapat dijadikan gel | |
HRP20020182B1 (hr) | Formulacije benzamida koje inhibiraju aktivnost histonskih deacetilaza | |
DK108192A (da) | Farmaceutisk praeparat med langsom frigivelse og anvendelse af forbindelse til fremstilling af praeparatet | |
RS51746B (sr) | Atorvastatin kalcijum u farmaceutskom obliku, njegovoj smeši i farmaceutskoj formulaciji, koja sadrži atorvastatin kalcijum | |
BRPI0507653A (pt) | derivados de imidazopiridina e imidazopiridina formulação farmacêutica compreendendo os mesmos e uso | |
ATE234634T1 (de) | Feste pharmazeutische formulierungen enthaltend eine physische mischung aus sulphoalkylethercyclodextrin und einem therapeutischen wirkstoff | |
FR2743562B1 (fr) | Derives de n-(arylsulfonyl) aminoacides, leur preparation, les compositions pharmaceutiques en contenant | |
ID28510A (id) | Formulasi oral yang baru untuk agonis atau antagonis 5-ht4 | |
SE0301701D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
DE60042831D1 (de) | Pharmazeutisch aktive sulfonylaminosäurederivate | |
RS52966B (en) | FORM OF THE THERAPEUTIC APPLICATION OF ACTIVE PEPTIDES WITH THE LONG TERM RELEASE OF THE ACTIVE INGREDIENT | |
AR018607A1 (es) | Preparacion farmaceutica que en calidad de ingrediente activo contiene levotiroxina sodica, y un procedimiento para su preparacion | |
ATE378335T1 (de) | Chirale fluorochinolizinon arginine salze | |
HUP9801712A2 (hu) | Racemizálás ellen stabilizált, cilansetrontartalmú gyógyászati készítmények, előállításuk és a stabilizáló adalékanyagok alkalmazása | |
EA200500671A1 (ru) | Фармацевтический состав оланзапина | |
PT1331001E (pt) | Nova formula galenica dispersivel e soluvel de paracetamol metodo para a sua preparacao e suas aplicacoes | |
DE60203997D1 (de) | Nasses granulationsverfahren zur herstellung von pharmazeutischen tabletten mit paroxetinhydrochlorid anhydrat | |
PT1290012E (pt) | Derivados amida do acido 2-amino-3-hidroxi-4-tert-leucil-amino-5-fenil-pentanoico | |
BRPI0407304A (pt) | Agentes antibacterianos | |
MEP18508A (hr) | Farmaceutski preparat i njegova priprema | |
BRPI0414319A (pt) | agentes antibacterianos de quinolona | |
ATE321530T1 (de) | Zusammensetzung enthaltend paroxetin und ein pharmazeutisch verträgliches salz von glycyrrhizinsäure | |
TH51543A3 (th) | รูปแบบยาของเนฟาโซโดน |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AIPI | Request for the grant of a patent on the basis of a substantive examination of a patent application | ||
A1OB | Publication of a patent application | ||
PNAN | Change of the applicant name, address/residence |
Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT, DE |
|
PNAN | Change of the applicant name, address/residence |
Owner name: BAYER PHARMA AKTIENGESELLSCHAFT, DE |
|
PPPP | Transfer of rights |
Owner name: BAYER INTELLECTUAL PROPERTY GMBH, DE |
|
B1PR | Patent granted | ||
ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20190725 Year of fee payment: 20 |
|
PB20 | Patent expired after termination of 20 years |
Effective date: 20200816 |